Albert Bourla, Pfizer CEO (Steven Ferdman/Getty Images)
November 11, 2020 07:27 AM ESTUpdated 09:51 AM
People
Coronavirus

As Pfiz­er's stock surged Mon­day, Al­bert Bourla net­ted $5.6M in stock sales

Jason Mast

Editor

On Mon­day morn­ing, Pfiz­er an­nounced they had de­vel­oped the first ef­fec­tive Covid-19 vac­cine, the world cel­e­brat­ed, their stock jumped 13% and their CEO be­came …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times